Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Arcosa Inc (ACA)

$35.72 0.17 (0.48%)

18:29 EDT ACA Stock Quote Delayed 30 Minutes

Volume:

Previous Close $35.72

Market Cap 1.74B

PE Ratio -

EPS -

Volume (Avg. Vol.) 249,200

Day's Range 35.07 - 35.99

52-Week Range 28.14 - 47.85

Dividend & Yield N/A (N/A)

ACA Stock Predictions, Articles, and Arcosa Inc News

From the Web

Is Redhill Biopharma (RDHL) Stock Outpacing Its Medical Peers This Year?

From Zacks Investment Research May 15, 2020

Is (RDHL) Outperforming Other Medical Stocks This Year?

20 Healthcare Stocks Moving In Tuesday's Pre-Market Session

From Benzinga May 12, 2020

Gainers • CymaBay Therapeutics, Inc. (NASDAQ:CBAY) shares increased by 144.02% to $4.49 during Tuesday's pre-market session. The most recent rating by Cantor Fitzgerald,...

Why Redhill Biopharma's Stock Is Trading Higher Today

From Benzinga May 8, 2020

Redhill Biopharma (NASDAQ: RDHL) shares are trading higher on Friday, after the company received FDA approval for its coronavirus clinical study with Opaganib in the U.S. Redhill...

17 Healthcare Stocks Moving In Friday's Pre-Market Session

From Benzinga May 8, 2020

Gainers • Therapix Biosciences, Inc. (NASDAQ:TRPX) shares rose 23.27% to $0.59 during Friday's pre-market session. • Pluristem Therapeutics, Inc. (NASDAQ:PSTI)...

RedHill Bio on go with mid-stage study of opaganib in COVID-19 (NASDAQ:RDHL)

From Seeking Alpha May 8, 2020

The FDA has signed off on RedHill Biopharma's (NASDAQ:RDHL) IND for a 40-subject Phase 2a clinical trial evaluating Yeliva (opaganib) in patients with moderate-to-severe COVID-19 infection.The primary

RedHill's CEO On Biopharma's 'Two Shots On Goal' For Coronavirus Drug

From Benzinga May 1, 2020

REDHILL BIOPHAR/S ADR (NASDAQ: RDHL), known primarily as a biopharmaceutical company focused on gastrointestinal diseases, is joining the race to develop coronavirus treatments...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold